Document is current
Any future updates will be listed below
-
Authors
Shibata, Mai https://orcid.org/0000-0001-5370-662X
Hatta, Toshifumi
Saito, Masako
Toyoshima, Junko
Kaneko, Yuichiro
Oda, Kazuo
Nishimura, Tetsuya
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01225224 at ClinicalTrials.govDocuments that mention this clinical trial
Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects
https://doi.org/10.1007/s40261-020-00910-w
-
Funding
Funding for this research was provided by:
Astellas Pharma Inc.
- License Information
-
More Information
Article History
First Online: 9 April 2020
Compliance with Ethical Standards
:
: This study was sponsored by Astellas Pharma Inc. Medical writing support was provided by Sarah Whitfield, Ph.D., for Cello Health MedErgy (Europe) and funded by Astellas Pharma Inc.
: M. Shibata, T. Hatta, M. Saito, J. Toyoshima, Y. Kaneko, and T. Nishimura are employees of Astellas Pharma Inc. K. Oda is an employee of Astellas Research Institute of America LLC.
: The study was reviewed and approved by the Institutional Review Board. The study was conducted in accordance with Good Clinical Practices, International Conference on Harmonisation guidelines, applicable regulations, and guidelines governing clinical study conduct and the ethical principles that have their origin in the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the study.
